Profile data is unavailable for this security.
About the company
Ansell Limited is an Australia-based provider of hand and body protection solutions and an integrated manufacturer, innovator and marketer of products. The Company is principally involved in the development, manufacturing and sourcing, distribution and sale of hand and body protection solutions in the industrial and healthcare markets. It provides protection solutions to approximately 25 specific industries and protects approximately 10 million workers each day. The Company operates through two segments: Industrial Global Business Unit (GBU) and Healthcare Global Business Unit (GBU). Healthcare GBU segment is engaged in surgical and examination gloves, healthcare safety devices and active infection prevention products for healthcare professionals and patients and single-use industrial application gloves. Industrial GBU segment is engaged in multi-use hand and body protection solutions for industrial work environments and specialty applications.
- Revenue in AUD (TTM)2.46bn
- Net income in AUD158.91m
- Incorporated1920
- Employees14.41k
- LocationAnsell LtdLevel 3, 678 Victoria StRICHMOND 3121AustraliaAUS
- Phone+61 39270-7270
- Fax+61 39270-7300
- Websitehttps://www.ansell.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Micro-Tech Nanjing Co Ltd | 468.67m | 103.79m | 2.61bn | 2.38k | 25.23 | 3.51 | -- | 5.57 | 2.60 | 2.60 | 11.74 | 18.69 | 0.5539 | 1.53 | 6.55 | 928,815.20 | 12.37 | 11.23 | 14.65 | 13.60 | 62.64 | 63.05 | 22.32 | 19.34 | 4.68 | -- | 0.0178 | 29.52 | 1.72 | 25.32 | 1.80 | 26.72 | 31.91 | -- |
Eyebright Medical Tchnlgy Beijing Co Ltd | 170.73m | 60.49m | 2.72bn | 871.00 | 45.14 | 6.20 | -- | 15.96 | 2.71 | 2.71 | 7.64 | 19.73 | 0.3404 | 1.52 | 5.06 | 925,695.00 | 11.67 | 9.28 | 12.89 | 10.12 | 80.03 | 84.33 | 34.29 | 35.90 | 5.52 | -- | 0.0742 | 20.76 | 33.81 | 50.60 | 35.80 | -- | 53.76 | -- |
Fukuda Denshi Co Ltd | 1.42bn | 195.26m | 2.74bn | 3.38k | 10.84 | 1.21 | 9.40 | 1.93 | 638.29 | 638.29 | 4,642.15 | 5,726.01 | 0.6919 | 3.30 | 4.08 | 41,521,290.00 | 9.51 | 7.50 | 11.26 | 9.60 | 53.61 | 45.27 | 13.75 | 9.96 | 3.31 | -- | 0.0103 | 28.85 | 1.93 | 0.879 | 6.55 | 13.14 | 10.88 | 14.87 |
Poly Medicure Ltd. | 239.61m | 45.68m | 2.79bn | 2.34k | 61.18 | -- | 48.87 | 11.66 | 25.90 | 25.90 | 135.86 | -- | -- | -- | -- | 5,577,489.00 | -- | 12.23 | -- | 15.06 | 65.03 | 55.45 | 19.06 | 15.11 | -- | 36.95 | -- | 17.98 | 20.82 | 16.41 | 22.37 | 20.49 | 23.75 | 8.45 |
Shenzhen YHLO Biotech Co Ltd | 507.49m | 89.82m | 2.90bn | 1.84k | 32.35 | 5.50 | -- | 5.71 | 0.7437 | 0.7437 | 4.21 | 4.37 | 0.6662 | 2.00 | 5.48 | 1,304,683.00 | 10.23 | -- | 13.71 | -- | 49.90 | -- | 15.36 | -- | 1.46 | -- | 0.2228 | -- | 237.95 | -- | 394.46 | -- | -- | -- |
Hartalega Holdings Berhad | 590.19m | -104.19m | 3.05bn | 7.56k | -- | 2.02 | -- | 5.16 | -0.0943 | -0.0943 | 0.5341 | 1.36 | 0.3316 | -- | 10.54 | 241,379.70 | -5.95 | 28.94 | -6.42 | 34.00 | -- | 46.86 | -17.94 | 29.87 | 4.84 | -37.13 | 0.0226 | 46.64 | -69.45 | 0.0331 | -107.27 | -- | 3.11 | -- |
Shanghai MicroPort Edvcl MdTch Grp CoLtd | 237.31m | 94.10m | 3.06bn | 786.00 | 28.27 | 6.43 | -- | 12.88 | 6.17 | 6.17 | 15.57 | 27.15 | 0.5372 | 1.59 | 8.40 | 1,425,843.00 | 21.04 | 19.64 | 23.48 | 21.68 | 75.28 | 77.11 | 39.17 | 42.53 | 5.27 | -- | 0.0196 | 38.25 | 30.95 | 40.26 | 12.99 | 41.29 | 59.78 | -- |
Ansell Ltd | 2.46bn | 158.91m | 3.08bn | 14.41k | 19.73 | 1.28 | 11.47 | 1.26 | 1.25 | 1.25 | 19.42 | 19.35 | 0.6312 | 1.84 | 8.15 | 170,436.20 | 4.13 | 6.60 | 4.96 | 7.89 | 37.99 | 37.83 | 6.55 | 9.50 | 0.9475 | 11.46 | 0.2418 | 42.17 | -15.21 | 2.13 | -6.55 | 4.31 | 8.02 | 0.8306 |
Beijing Balance Medical Technolgy Co Ltd | 70.26m | 22.37m | 3.18bn | 355.00 | 142.10 | 13.01 | -- | 45.32 | 0.7748 | 0.7748 | 2.43 | 8.46 | 0.2791 | 1.20 | 5.18 | 934,697.70 | 8.70 | 8.35 | 9.08 | 8.67 | 88.77 | 89.43 | 31.17 | 30.20 | 12.83 | -- | 0.0115 | 51.60 | 17.21 | 26.16 | 85.82 | 17.65 | 51.59 | -- |
Shanghai Haohai Biological Technology | 558.66m | 88.23m | 3.23bn | 2.16k | 14.93 | 1.08 | 24.95 | 5.78 | 2.65 | 2.65 | 16.75 | 36.65 | 0.3765 | 1.55 | 7.37 | 1,323,530.00 | 5.89 | 4.84 | 6.86 | 5.50 | 70.34 | 72.09 | 15.65 | 16.50 | 4.50 | -- | 0.0635 | 36.76 | 25.27 | 11.26 | 130.58 | 0.0762 | -- | 14.27 |
Holder | Shares | % Held |
---|---|---|
Allan Gray (Pty) Ltd.as of 05 Oct 2023 | 23.89m | 18.99% |
The Vanguard Group, Inc.as of 29 Dec 2023 | 6.67m | 5.30% |
Australian Retirement Trust Pty Ltd.as of 15 Dec 2023 | 6.31m | 5.02% |
State Street Global Advisors, Australia, Ltd.as of 09 Mar 2023 | 6.12m | 4.87% |
Allan Gray Australia Pty Ltd.as of 31 Dec 2023 | 5.84m | 4.65% |
First Sentier Investors (Australia) IM Ltd.as of 24 Jun 2022 | 3.45m | 2.74% |
Dimensional Fund Advisors LPas of 07 Mar 2024 | 2.90m | 2.31% |
Vanguard Investments Australia Ltd.as of 29 Feb 2024 | 2.18m | 1.74% |
Harris Associates LPas of 31 Dec 2023 | 1.69m | 1.35% |
BlackRock Fund Advisorsas of 07 Mar 2024 | 1.46m | 1.16% |